Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT07193602
Eligibility Criteria:
Inclusion Criteria:
* MS patients with relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS) or primary progressive MS (PPMS) according to the revised McDonald's criteria (Thompson et al. 2017).
Age between 18 and 75 years.
Written informed consent signed by the subject must be obtained prior to study start
Patient must complain about MS related impaired manual dexterity negatively affecting ADL and/or QoL.
Patients must have a pathological 9-Hole-Peg-Test (9HPT) as defined by Oxford Grice et al. 2003.
Patients must have Arm function in multiple sclerosis questionnaire (AMSQ) score \>41
Exclusion Criteria:
* A relapse that started within 60 days prior to screening.
Rapidly progressive disease.
Any disease/condition that impaired manual dexterity besides MS
Any disease other than MS that could possibly explain the patient's signs and symptoms
Medical or psychiatric conditions that compromise the ability to comply with the protocol, or to complete the study
A history of drug abuse in the 12 months prior to screening
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07193602
Study Brief:
Protocol Section:
NCT07193602